Abstract To date, generic questionnaires have been used to investigate quality of life (QoL) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients. Although these measures are very useful, they are not usually precise enough to measure all specific characteristics of the disease. Our aim was to investigate QoL using the neuromuscular disease-specific questionnaire (Individualized Neuromuscular Quality of Life, INQoL) in a large cohort of patients with CIDP. Our study comprised 106 patients diagnosed with CIDP. INQoL questionnaire, Medical Research Council (MRC) sum score, Inflammatory Neuropathy Cause and Treatment (INCAT) disability score, Visual Analogue Pain Scale, Beck Depression Inventory, and Krupp's Fatigue Severity Scale were used in our study. Physical domains of INQoL were more affected than mental, and the overall score was 57 ± 25. Significant predictors of higher INQoL score in our patients with CIDP were severe fatigue ( = 0.35, p < 0.01), higher INCAT disability score at time of testing ( = 0.29, p < 0.01), and being unemployed/retired ( = 0.22, p < 0.05). QoL was reduced in our cohort of CIDP patients, which was more pronounced in physical segments. Patients with fatigue, more severe disability, and unemployed/retired need special attention of neurologists because they could be at greater risk to have worse QoL.
Introduction
Generic questionnaires have been used to investigate quality of life (QoL) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients.
( Symonds et al., 2017) . To our knowledge, INQoL was mostly used in patients with muscle disorders, especially myotonic dystrophies both in our country and abroad (Sansone et al., 2010; Peric et al., 2011; Seesing et al., 2015; Baldanzi et al., 2016; Fagoaga et al., 2017) . It was suggested that INQoL could have advantages in assessment of QoL in different neuromuscular disorders over generic patient reported outcome measures (Peric et al., 2011; Draak et al., 2017) .
The aim of our study was to investigate QoL using a neuromuscular disease-specific questionnaire (INQoL) in a large cohort of patients with CIDP.
Materials and Methods
We designed the INeSS (Inflammatory Neuropathy Study of Serbia) to collect as many as patients with CIDP from Serbia, Republic of Srpska (Bosnia and Herzegovina) and Montenegro. We sought to examine all CIDP patients diagnosed in tertiary health care centers in a 10-year period between 2007 and 2016. Patients were included if they fulfilled the European Federation of Neurological Societies/Peripheral Nerve Society diagnostic criteria, and the same criteria were also used to establish variants of the disease (Van den Bergh et al., 2010) . We identified 190 patients, whereby at the time of study 26 of them were dead, 32 were lost from follow-up, 11 refused to participate in the study, and 2 did not fill more than half questions of INQoL. In order to have a CIDP-only cohort, and since we were not able to analyze sera for the presence of anti-MAG antibodies, four patients who were positive for IgM paraprotein were excluded. Furthermore, we excluded 9 patients due to other severe diseases (stroke, hematological malignancy, connective tissue disease, motor neuron disease, and neurofibromatosis) making overall number of 106 tested patients. The Ethical Board of the Neurology Clinic, Clinical Center of Serbia approved our study, and all our patients gave informed consent to participate. Sociodemographic data were investigated from patients' medical records at time of diagnosis and at time of the testing. We also analyzed therapeutic modality and response to treatment, presence of significant comorbid disorders such as diabetes mellitus and monoclonal gammopathy of undetermined significance (MGUS) excluding IgM. Evaluation of the muscle strength was done using the Medical Research Council scale (MRC sum score) (Kleyweg et al., 1991) . At time of diagnosis and at the time of testing, degree of functional disability was measured using the INCAT disability scale (Inflammatory Neuropathy Cause and Treatment score) (Breiner et al., 2014) . The INCAT sensory score was applied to rate the sensory deficit (Draak et al., 2015) .
Average pain intensity was detected using the self-assessment Visual Analogue Scale (VAS). Severity of fatigue was measured by Krupp's Fatigue Severity Scale (FSS) (Krupp et al., 1989) . We assessed depression using the Beck's Depression Inventory (BDI) (Beck et al., 1988) .
We used the (INQoL) questionnaire, which consists of 45 questions divided into 10 sections. INQoL is protected by Dr. M. R. Rose & King's College NHS-Trust, and we obtained permission to use it only in academic purposes. Common neuromuscular symptoms (weakness, locking/aka myotonia/pain and fatigue) were measured by the first four sections. These sections are not included in the total INQoL score and they were designed in order to separate symptom effects from disease impact on life domains, allowing analysis of the response shift phenomenon. Next five sections examine the influence of the disease on particular segments of life (activities, independence, relationships, emotions, and body image) and only these sections are included in the total INQoL score (Vincent et al., 2007) . INQoL uses weighted responses rather than taking an average of the percentages of different items. Four each aforementioned segment of life, a patient is asked about his/her satisfaction with certain life aspect and about estimation of the influence of a particular neuromuscular disease on that aspect. The last section investigates the treatment of the disease. The final score for each section and total INQoL score are presented as a percentage whereby a higher percentage indicates a worse QoL.
Normality of data was evaluated using the Kolmogorov-Smirnov test. For group comparisons, 2 test, Mann-Whitney U-test and Student's t-test were used for group comparisons, as appropriate. Correlations were estimated using Spearman's rho. Factors that significantly correlated with INQoL total score in univariate analysis (p < 0.05) were included in the multiple linear regression analysis (stepwise method). Stepwise criteria were as follows: probability of F to enter variable was ≤0.05, and probability to remove variable ≥0.10. SPSS software (IBM Corp. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY) created three models with INQoL total score as a dependent variable. The model with the highest adjusted R 2 value was considered. In this way, we identified independent predictors of QoL. For all statistical tests, significant testing was two-sided, where alpha was set at 0.05 for statistical significance and at 0.01 for high statistical significance.
Results
Main sociodemographic and clinical features of our cohort are presented in Table 1 . As expected, INCAT scores (disability, sensory, and total) were lower and MRC sum score was higher at time of investigation compared to the baseline data. Severe fatigue was present in 43% of our patients, and mean FSS score was 35 ± 17. Mean score on BDI scale was 8.2 ± 7.6, and 31% of patients had depression. More than half of our patients complained of pain, while the mean score representing pain on VAS was 2.5 ± 3.0. Mean total INQoL score was 43.6 ± 22.2. Among neuromuscular symptoms, the best scores were obtained for locking and pain, while the worst results were found for weakness ( Table 2) . Analysis of neuromuscular symptoms showed that weakness was the most frequent (71%), followed by fatigue (64%) and pain (59%), and with locking being the rarest complaint (50%). Self-estimation of the severity of symptoms (maximum grade is 7) showed that weakness also was of the highest degree compared to fatigue, pain, and especially locking (4.4 ± 1.7 vs. 4.0 ± 1.7 vs. 4.0 ± 1.7 vs. 3.7 ± 1.8, respectively). Degree of problems that certain symptom causes was rated as 3.4 ± 1.8 for weakness, 3.1 ± 1.7 for fatigue, 3.0 ± 1.9 for pain, and expectedly only 2.7 ± 1.9 for locking. Importance of the problems caused by certain symptom was self-rated as 4.2 ± 3.5 for weakness, while other symptoms were less important (3.5 ± 1.9 for fatigue and locking, and 3.4 ± 1.8 for pain).
In the section examining the influence of the disease on particular segments of life, the best score was found for social activities and the worst for activities. Associations between different sociodemographic/clinical factors and total INQoL score are presented in Table 3 . The most significant predictors of higher total INQoL score (i.e., worse QoL) in our cohort were severe fatigue ( = 0.35, p < 0.01), worse INCAT disability at time of testing ( = 0.29, p < 0.01), and being retired/unemployed ( = 0.22, p < 0.05) ( Table 4) . 
Discussion
In our cohort of CIDP patients QoL was expectedly reduced. The worst INQoL scores were weakness and fatigue among symptom domains and activities among life areas. Weakness was self-estimated as the most important symptom. All these indicate that the physically oriented sections were more affected than psychosocial ones. One of the reasons could be the fact that physical recovery in CIDP is often limited with common residual symptoms (Draak et al., 2017) . In contrast to previous studies where both physical and mental aspects were usually equally impaired in patients with myotonic dystrophy type 1 and 2 (Tieleman et al., 2011; Peric et al., 2013; Baldanzi et al., 2016; Rakocevic-Stojanovic et al., 2016) , our results suggest that psychological and social domains in CIDP patients are mostly preserved. It seems that CIDP patients are able to cope better with their illness and to preserve certain domains of their life. Although both disability and sensory scores at baseline and at time of testing correlated with QoL, our results showed that higher INCAT disability score at time of testing was a predictor of the worse total INQoL score. Considering INCAT disability scale as an activity measure used for detecting patient's daily functioning such as precise manual activities and problems with walking, this result is another confirmation that in our cohort of patients with CIDP physical disability affected QoL to a major extent. Previous findings also indicated that INCAT score had high associations with QoL scores, especially with physically oriented domains (Merkies and Schmitz, 2006; Bozovic et al., 2017) . On the other hand, in our study physical disability was not the most significant predictor of QoL, which is in accordance with the findings of Merkies et al. ( 2010) where only 20% of the variance of the physical composite score of SF-36 was explained by INCAT measure.
Almost half of our patients complained of severe fatigue, which together with previous results of up to 68% of CIDP patients with this symptom, underlines fatigue as one of the main symptoms of the disease from patients' perspective (Westblad et al., 2009; Merkies and Faber, 2012; Bozovic et al., 2017) . Some previous studies have reported that fatigue was not only a significant obstacle in patients with CIDP, but also may be the main cause of referral to neurologist in these patients (Boukhris et al., 2005) . Although the main etiology of fatigue in immune-mediated neuropathies still remains unclear, it is suspected to be multi-factorial and that both central and peripheral mechanisms may be included (Garssen et al., 2007) . As fatigue is one of the main predictors which correlates with worse QoL, not only in CIDP patients but also in other neuromuscular disorders (Kalkman et al., 2005; Rakocevic-Stojanovic et al., 2014; Rakocevic-Stojanovic et al., 2016) , it could be therapeutically targeted in order to improve patients' daily functioning. Physical exercise, cognitive therapy, treatment of associated pain depression, sleep disturbances, and potential metabolic comorbidities could be the main therapeutic modalities for fatigue treatment in different neuromuscular disorders (Lou et al., 2010) .
Our findings indicate that employment status was one of the independent predictors of QoL in CIDP patients, where being unemployed or retired directly correlated with worse QoL. We obtained similar results using SF-36 generic QoL questionnaire (Bozovic et al., 2017) . The main reason could lie in the fact that patients with more severe physical disability are usually unemployed, but also their unemployment could further affect their mental homeostasis. It was noted in a recent UK study that around 32% of CIDP patients retired early because of their disease (Mahdi-Rogers et al., 2014) , which represents a high and increasing number of people whose QoL could be disturbed. We suppose that significant attention should be focused on appropriate management strategies and sustained employment of CIDP patients, including professional job prequalification. Further studies to solve this issue are needed.
When we compare results from our previous study in which we used generic SF-36 questionnaire on almost the same cohort of CIDP patients, we can see similar pattern of QoL predictors: fatigue, functional disability at time of testing, and employment status (Bozovic et al., 2017) . However, we previously observed correlation of SF-36 score with depression and disease duration which was not observed for the INQoL total score. Furthermore, 69% of the variance of SF-36 score was explained by investigated demographic, clinical and psychosocial factors, and only 43% of the variance of INQoL score, which suggest that INQoL might comprise life domains not assessed by generic questionnaire. For example, INQoL is able to give answers about independence and body image that are not comprised by SF-36. In INQoL, symptom effects are separated from disease impact on life domains, thus improvement in symptoms may be separated from the improvement in subjective perception of QoL, allowing analysis of the response shift phenomenon in future prospective studies. However, INQoL did not show good responsiveness in a 6-year longitudinal study of QoL in patients with myotonic dystrophy type 1 and similar studies are needed in patients with CIDP but with shorter interval follow-up period . It is also true that there are other validated subjective outcome measures on fatigue and pain, but it is much easier to have all these in one questionnaire. On the other hand, it should be mentioned that locking (aka myotonia) domain is not of interest in CIDP and was included in INQoL because of myotonic dystrophies and muscle channelopathies. Another limitation of INQoL is a lack of certain symptoms specific for CIDP such as sensory disturbances, ataxia, tremor, etc. Thus, we suggest that new version of INQoL comprising more specific symptoms for CIDP should be constructed. It is probably even better to use newly created interval-based QoL questionnaire for inflammatory neuropathies (IN-QoL), but it should be translated and transculturally validated in different countries (Draak et al., 2017) .
